Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days

Human Reproduction

Volumn 25, Issue 5, 2010, Pages 1153-1157

  Kopp Kallner, H ^a   Fiala, C ^b   Stephansson, O ^a   Gemzell Danielsson, K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Gynmed Clinic   (Austria)

Author keywords

Acceptability; Home administration; Medical abortion; Mifepristone; Termination of pregnancy

Indexed keywords

CODYDRAMOL; DICLOFENAC; DOXYCYCLINE; HEXOBARBITAL; METRONIDAZOLE; MIFEPRISTONE; MISOPROSTOL;

ADULT; ARTICLE; CHLAMYDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG UTILIZATION; FAMILY PLANNING; FATIGUE; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; MEDICAL ABORTION; MEDICAL RECORD REVIEW; NAUSEA; OBSTETRIC ANALGESIA; OUTPATIENT; PAIN; PREGNANCY TERMINATION; PROSPECTIVE STUDY; QUESTIONNAIRE; UNIVERSITY HOSPITAL; VAGINITIS; VOMITING;

EID: 77951111127     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq037     Document Type: Article

References (13)

1. Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998;13:2962-2965.
2. Bartley J, Baird DT. A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy. BJOG 2002;109:1290-1294.
3. Creinin MD, Schreiber CA, Bednarek P, Lintu H, Wagner MS, Meyn LA. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol 2007;109:885-894.
4. Fiala C, Gemzell-Danielsson K. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception 2006;74:66-86.
5. Fiala C, Winikoff B, Helstrom L, Hellborg M, Gemzell-Danielsson K. Acceptability of home-use of misoprostol in medical abortion. Contraception 2004;70:387-392. (Pubitemid 39422516)
6. Fischer M, Bhatnagar J, Guarner J, Reagan S, Hacker JK, Van Meter SH, Poukens V, Whiteman DB, Iton A, Cheung M et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med 2005;353:2352-2360.
7. Hamoda H, Critchley HO, Paterson K, Guthrie K, Rodger M, Penney GC. The acceptability of home medical abortion to women in UK settings. BJOG 2005;112:781-785.
8. Henshaw RC, Naji SA, Russell IT, Templeton AA. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment. BMJ 1993;307:714-717.
9. Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract 1997;44:353-360.
10. Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999;59:1-6.
11. Schaff EA, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS, Fuller L. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial. JAMA 2000;284:1948-1953.
12. Westhoff C, Dasmahapatra R, Schaff E. Analgesia during at-home use of misoprostol as part of a medical abortion regimen. Contraception 2000;62:311-314. (Pubitemid 32182418)
13. Winikoff B. Acceptability of medical abortion in early pregnancy. Fam Plann Perspect 1995;27:142-148.